Cirrhosis
Cirrhosis is a chronic, degenerative disease in which normal liver cells are damaged and are then replaced by scar tissue.
Cirrhosis - most related articles:
-
Curcumin in turmeric may delay liver damage, cirrhosis - 4.7
-
Incivek for hepatitis C infection is approved in US - 3.8
-
Hepatitis C declines health with liver disease - 2.7
-
Vitamin E or metformin not effective in liver disease in children teens - 2.5
-
Hepatitis B hits men harder than women due to an abnormal protein - 2.5
Cirrhosis articles
Incivek for hepatitis C infection is approved in USThe U.S. Food and Drug Administration approved Incivek (telaprevir) to treat certain adults with chronic hepatitis C infection. Incivek is used for patients who have either not received interferon-based drug therapy for their infection or who have not responded adequately to prior therapies.
Curcumin in turmeric may delay liver damage, cirrhosisCurcumin, one of the principal components of the Indian spice turmeric, seems to delay the liver damage that eventually causes cirrhosis, suggests preliminary experimental research in the journal Gut.
1 in 25 deaths attributable to alcohol1 in 25 deaths are directly attributable to alcohol consumption worldwide, revealed by researchers from Canada's Centre for Addiction and Mental Health (CAMH).
Positive results of Albuferon in Chronic Hepatitis CHuman Genome Sciences, Inc. (Nasdaq: HGSI) announced that Albuferon (albinterferon alfa-2b) met its primary endpoint of non-inferiority to peginterferon alfa-2a (Pegasys) in ACHIEVE 1, a Phase 3 clinical trial of Albuferon in combination with ribavirin in treatment-naive patients with genotype 1 chronic hepatitis C (p=0.0008).
Heart tissue can be saved after heart attacksA heart damaged by heart attack is usually broken, at least partially, for good. The injury causes excessive scar tissue to form, and this plays a role in permanently keeping heart muscle from working at full capacity.
Hepatitis C declines health with liver diseaseAn NIH funded multi-center clinical trial found no benefit from "maintenance therapy," low-dose peginterferon used for hepatitis C patients who have not responded to an initial round of treatment.
MRI for better assessment of liver fibrosisMRI imagery is emerging as a non-invasive way to determine the existence and extent of hepatic fibrosis. It could eventually help the development of pharmacologic strategies to combat the condition.
7 Cirrhosis articles listed above.
Mission
Health Newstrack is dedicated to serve recent and updated health & medical research, events/news, views/reviews to its subscribers and free access to general public, health & medical professionals, and other health seekers worldwide online with a user-friendly system.
What is Cirrhosis
Cirrhosis is a chronic, degenerative disease in which normal liver cells are damaged and are then replaced by scar tissue.